EP0834330B1
(en)
*
|
1993-07-31 |
2003-11-26 |
Aradigm Corporation |
Needle-less injector
|
FR2718357B1
(en)
*
|
1994-04-06 |
1997-10-03 |
Defarges Alain Moreau |
Improvements made to a needleless jet injection device.
|
US6474369B2
(en)
|
1995-05-26 |
2002-11-05 |
Penjet Corporation |
Apparatus and method for delivering a lyophilized active with a needle-less injector
|
US5899879A
(en)
*
|
1995-12-19 |
1999-05-04 |
Genesis Medical Technologies, Inc. |
Spring-actuated needleless injector
|
US5800388A
(en)
|
1996-02-29 |
1998-09-01 |
Medi-Ject Corporation |
Plunger/ram assembly adapted for a fluid injector
|
US5921967A
(en)
|
1996-02-29 |
1999-07-13 |
Medi-Ject Corporation |
Plunger for nozzle assembly
|
US5769138A
(en)
*
|
1996-04-01 |
1998-06-23 |
Medi-Ject Corporation |
Nozzle and adapter for loading medicament into an injector
|
US6374255B1
(en)
|
1996-05-21 |
2002-04-16 |
Immersion Corporation |
Haptic authoring
|
US6458574B1
(en)
|
1996-09-12 |
2002-10-01 |
Transkaryotic Therapies, Inc. |
Treatment of a α-galactosidase a deficiency
|
US5875976A
(en)
|
1996-12-24 |
1999-03-02 |
Medi-Ject Corporation |
Locking mechanism for nozzle assembly
|
US7347840B2
(en)
*
|
2000-03-02 |
2008-03-25 |
Pyng Medical Corp. |
Patch for locating a target zone for penetration
|
US6761726B1
(en)
*
|
1998-05-15 |
2004-07-13 |
Pyng Medical Corp. |
Method and apparatus for the intraosseous introduction of a device such as an infusion tube
|
US5911703A
(en)
*
|
1997-05-22 |
1999-06-15 |
Avant Drug Delivery Systems, Inc. |
Two-stage fluid medicament jet injector
|
US6030399A
(en)
*
|
1997-06-04 |
2000-02-29 |
Spectrx, Inc. |
Fluid jet blood sampling device and methods
|
US5947928A
(en)
*
|
1997-06-19 |
1999-09-07 |
Mile Creek Capital, Llc |
Drug delivery system
|
US6004287A
(en)
*
|
1997-09-23 |
1999-12-21 |
Loomis; Dale J |
Biolistic apparatus for delivering substances into cells and tissues
|
US6071272A
(en)
*
|
1997-10-28 |
2000-06-06 |
Hoffman; Alan S. |
Method for treating erectile dysfunctionality
|
US6256011B1
(en)
|
1997-12-03 |
2001-07-03 |
Immersion Corporation |
Multi-function control device with force feedback
|
US6610042B2
(en)
|
1997-12-05 |
2003-08-26 |
Felton Medical, Inc. |
Disposable unit-dose jet-injection syringe for pre-filled and/or transfilled liquid injectable medical drug or vaccine products and method thereof
|
JP2002517300A
(en)
*
|
1998-06-10 |
2002-06-18 |
ジョージア テック リサーチ コーポレイション |
Microneedle devices and methods of manufacture and uses thereof
|
US6503231B1
(en)
*
|
1998-06-10 |
2003-01-07 |
Georgia Tech Research Corporation |
Microneedle device for transport of molecules across tissue
|
ATE342079T1
(en)
*
|
1998-07-27 |
2006-11-15 |
Antares Pharma Inc |
INJECTION AUXILIARY TORPEDO FOR A MEDICAL INJECTION SYSTEM
|
AU5317699A
(en)
|
1998-07-27 |
2000-02-21 |
Medi-Ject Corporation |
Loading mechanism for medical injector assembly
|
US6428528B2
(en)
|
1998-08-11 |
2002-08-06 |
Antares Pharma, Inc. |
Needle assisted jet injector
|
JP2000107289A
(en)
*
|
1998-10-05 |
2000-04-18 |
Showa Yakuhin Kako Kk |
Cartridge type dental syringe unit
|
US6506177B2
(en)
*
|
1998-10-14 |
2003-01-14 |
Sergio Landau |
Needle-less injection system
|
US6406455B1
(en)
*
|
1998-12-18 |
2002-06-18 |
Biovalve Technologies, Inc. |
Injection devices
|
DE19859137C1
(en)
*
|
1998-12-21 |
2000-05-18 |
Ferton Holding Sa |
High pressure medicinal injection unit includes piston advanced into pressure chamber by series of resilient impacts, forcing fluid out in series of impulses for precise low-volume dosing
|
US6258062B1
(en)
*
|
1999-02-25 |
2001-07-10 |
Joseph M. Thielen |
Enclosed container power supply for a needleless injector
|
US7060048B1
(en)
*
|
1999-04-16 |
2006-06-13 |
Powerject Research Limited |
Needleless syringe
|
WO2000064514A1
(en)
*
|
1999-04-22 |
2000-11-02 |
Gilbert Garitano |
Needleless permanent makeup and tattoo device
|
US7171264B1
(en)
*
|
1999-05-10 |
2007-01-30 |
Genetronics, Inc. |
Intradermal delivery of active agents by needle-free injection and electroporation
|
US7192713B1
(en)
|
1999-05-18 |
2007-03-20 |
President And Fellows Of Harvard College |
Stabilized compounds having secondary structure motifs
|
EP1754488A1
(en)
|
1999-05-24 |
2007-02-21 |
Introgen Therapeutics, Inc. |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
US6611707B1
(en)
|
1999-06-04 |
2003-08-26 |
Georgia Tech Research Corporation |
Microneedle drug delivery device
|
US6743211B1
(en)
|
1999-11-23 |
2004-06-01 |
Georgia Tech Research Corporation |
Devices and methods for enhanced microneedle penetration of biological barriers
|
US6626871B1
(en)
|
1999-10-11 |
2003-09-30 |
Felton International, Inc. |
Method and apparatus for removing cap from medical device
|
US7074210B2
(en)
*
|
1999-10-11 |
2006-07-11 |
Felton International, Inc. |
Universal protector cap with auto-disable features for needle-free injectors
|
US6776776B2
(en)
*
|
1999-10-14 |
2004-08-17 |
Becton, Dickinson And Company |
Prefillable intradermal delivery device
|
US20020193740A1
(en)
|
1999-10-14 |
2002-12-19 |
Alchas Paul G. |
Method of intradermally injecting substances
|
US6494865B1
(en)
|
1999-10-14 |
2002-12-17 |
Becton Dickinson And Company |
Intradermal delivery device including a needle assembly
|
US6843781B2
(en)
*
|
1999-10-14 |
2005-01-18 |
Becton, Dickinson And Company |
Intradermal needle
|
US6569123B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Prefillable intradermal injector
|
US6569143B2
(en)
|
1999-10-14 |
2003-05-27 |
Becton, Dickinson And Company |
Method of intradermally injecting substances
|
US6382204B1
(en)
|
1999-10-14 |
2002-05-07 |
Becton Dickinson And Company |
Drug delivery system including holder and drug container
|
US6673035B1
(en)
*
|
1999-10-22 |
2004-01-06 |
Antares Pharma, Inc. |
Medical injector and medicament loading system for use therewith
|
AU784838B2
(en)
|
1999-10-22 |
2006-07-06 |
Antares Pharma, Inc. |
Medical injector and medicament loading system for use therewith
|
US6391003B1
(en)
|
1999-10-25 |
2002-05-21 |
Antares Pharma, Inc. |
Locking mechanism for a jet injector
|
US7887506B1
(en)
|
1999-11-23 |
2011-02-15 |
Pulse Needlefree Systems, Inc. |
Safety mechanism to prevent accidental patient injection and methods of same
|
US7029457B2
(en)
*
|
1999-11-23 |
2006-04-18 |
Felton International, Inc. |
Jet injector with hand piece
|
US6770054B1
(en)
|
1999-11-23 |
2004-08-03 |
Felton International, Inc. |
Injector assembly with driving means and locking means
|
US6693626B1
(en)
|
1999-12-07 |
2004-02-17 |
Immersion Corporation |
Haptic feedback using a keyboard device
|
CA2396569C
(en)
*
|
2000-01-07 |
2010-03-23 |
Biovalve Technologies, Inc. |
Injection device
|
CA2331030A1
(en)
*
|
2000-02-16 |
2001-08-16 |
Roche Diagnostics Gmbh |
Hypodermic needleless injection system
|
US6689092B2
(en)
*
|
2000-03-03 |
2004-02-10 |
Boehringer International Gmbh |
Needle-less injector of miniature type
|
EP1265663B1
(en)
*
|
2000-03-23 |
2011-03-02 |
Antares Pharma, Inc. |
Single use disposable jet injector
|
GB0008494D0
(en)
|
2000-04-07 |
2000-05-24 |
Secr Defence |
Microprojectile delivery system
|
US10293056B1
(en)
|
2000-05-24 |
2019-05-21 |
Board Of Regents, The University Of Texas System |
Methods and compositions for non-viral gene therapy for treatment of hyperproliferative diseases
|
US6629958B1
(en)
|
2000-06-07 |
2003-10-07 |
Ronald P. Spinello |
Leak sealing needle
|
US6406456B1
(en)
|
2000-06-08 |
2002-06-18 |
Avant Drug Delivery Systems, Inc. |
Jet injector
|
US20020046486A1
(en)
*
|
2000-07-10 |
2002-04-25 |
Wild Peter M. |
Woody plant injection method and apparatus
|
US6695817B1
(en)
|
2000-07-11 |
2004-02-24 |
Icu Medical, Inc. |
Medical valve with positive flow characteristics
|
DE10034270A1
(en)
*
|
2000-07-14 |
2002-02-14 |
Disetronic Licensing Ag |
Storage container with a metering device for the metered delivery of an injectable product to an injection device
|
GB0022742D0
(en)
|
2000-09-15 |
2000-11-01 |
Smithkline Beecham Biolog |
Vaccine
|
US6610033B1
(en)
*
|
2000-10-13 |
2003-08-26 |
Incept, Llc |
Dual component medicinal polymer delivery system and methods of use
|
US7575924B2
(en)
|
2000-11-13 |
2009-08-18 |
Research Development Foundation |
Methods and compositions relating to improved lentiviral vectors and their applications
|
AU2003222427B8
(en)
*
|
2000-11-17 |
2010-04-29 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same
|
US8071740B2
(en)
*
|
2000-11-17 |
2011-12-06 |
Vascular Biogenics Ltd. |
Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
|
US7931614B2
(en)
*
|
2000-11-30 |
2011-04-26 |
Valeritas, Inc. |
Injection systems
|
CA2429769C
(en)
*
|
2000-12-07 |
2016-04-26 |
Board Of Regents, The University Of Texas System |
Methods of treatment involving human mda-7
|
WO2002064193A2
(en)
|
2000-12-14 |
2002-08-22 |
Georgia Tech Research Corporation |
Microneedle devices and production thereof
|
EP1361890B1
(en)
|
2001-02-23 |
2011-03-30 |
GlaxoSmithKline Biologicals s.a. |
Influenza vaccine formulations for intradermal delivery
|
US6500239B2
(en)
|
2001-03-14 |
2002-12-31 |
Penjet Corporation |
System and method for removing dissolved gas from a solution
|
GB0109297D0
(en)
|
2001-04-12 |
2001-05-30 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US6613010B2
(en)
*
|
2001-04-13 |
2003-09-02 |
Penjet Corporation |
Modular gas-pressured needle-less injector
|
US20050192530A1
(en)
*
|
2001-04-13 |
2005-09-01 |
Penjet Corporation |
Method and apparatus for needle-less injection with a degassed fluid
|
US6755220B2
(en)
|
2001-04-27 |
2004-06-29 |
Penjet Corporation |
Method and apparatus for filling or refilling a needle-less injector
|
US20100221284A1
(en)
|
2001-05-30 |
2010-09-02 |
Saech-Sisches Serumwerk Dresden |
Novel vaccine composition
|
TWI228420B
(en)
|
2001-05-30 |
2005-03-01 |
Smithkline Beecham Pharma Gmbh |
Novel vaccine composition
|
US6752781B2
(en)
*
|
2001-06-08 |
2004-06-22 |
Sergio Landau |
Durable hypodermic jet injector apparatus and method
|
DE10129583A1
(en)
*
|
2001-06-20 |
2003-01-09 |
Disetronic Licensing Ag |
Device and method for injection
|
US20060018877A1
(en)
*
|
2001-06-29 |
2006-01-26 |
Mikszta John A |
Intradermal delivery of vacccines and therapeutic agents
|
WO2003002069A2
(en)
*
|
2001-06-29 |
2003-01-09 |
Becton, Dickinson And Company |
Intradermal delivery of vaccines and gene therapeutic agents via microcannula
|
JP4792670B2
(en)
*
|
2001-07-23 |
2011-10-12 |
株式会社島津製作所 |
Needleless syringe
|
WO2003012054A2
(en)
|
2001-08-02 |
2003-02-13 |
Institut Clayton De La Recherche |
Methods and compositions relating to improved lentiviral vector production systems
|
AU2002326661A1
(en)
|
2001-08-17 |
2003-03-03 |
Antares Pharma, Inc. |
Administration of insulin by jet injection
|
GB2391480B
(en)
*
|
2002-08-05 |
2007-02-28 |
Caretek Medical Ltd |
Drug delivery system
|
GB2379390B
(en)
*
|
2001-09-11 |
2005-01-26 |
Caretek Medical Ltd |
A novel drug delivery technology
|
US7615234B2
(en)
*
|
2001-09-11 |
2009-11-10 |
Glide Pharmaceutical Technologies Limited |
Drug delivery technology
|
WO2003024507A2
(en)
*
|
2001-09-19 |
2003-03-27 |
Biovalve Technologies, Inc. |
Microneedles, microneedle arrays, and systems and methods relating to same
|
AU2002330083A1
(en)
*
|
2001-09-21 |
2003-04-01 |
Biovalve Technologies, Inc. |
Gas pressure actuated microneedle arrays, and systems and methods relating to same
|
WO2003026733A2
(en)
*
|
2001-09-28 |
2003-04-03 |
Biovalve Technologies, Inc. |
Microneedle with membrane
|
CA2500452A1
(en)
*
|
2001-09-28 |
2003-04-03 |
Biovalve Technologies, Inc. |
Switchable microneedle arrays and systems and methods relating to same
|
RU2305708C2
(en)
|
2001-10-02 |
2007-09-10 |
Энститю Клейтон Де Ля Решерш |
Recombinant lentiviral vector, host cell transduced with lentiviral vector, methods for transduction and uses thereof
|
EP1436313B1
(en)
|
2001-10-19 |
2010-09-22 |
Vascular Biogenics Ltd. |
Polynucleotide constructs, pharmaceutical compositions and methods for targeted downregulation of angiogenesis and anticancer therapy
|
US6824526B2
(en)
|
2001-10-22 |
2004-11-30 |
Penjet Corporation |
Engine and diffuser for use with a needle-less injector
|
GB0125506D0
(en)
*
|
2001-10-24 |
2001-12-12 |
Weston Medical Ltd |
Needle free injection method and apparatus
|
US6607510B2
(en)
*
|
2001-11-09 |
2003-08-19 |
Bioject Medical Technologies Inc. |
Disposable needle-free injection apparatus and method
|
US20030130614A1
(en)
*
|
2002-01-09 |
2003-07-10 |
Johnson Lanny L. |
Device for delivering liquid medications or nutrients and gases to local tissue
|
GB2384527B
(en)
*
|
2002-01-23 |
2004-07-14 |
Bespak Plc |
Dispensing device
|
US6875205B2
(en)
*
|
2002-02-08 |
2005-04-05 |
Alaris Medical Systems, Inc. |
Vial adapter having a needle-free valve for use with vial closures of different sizes
|
CA2477780A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Board Of Regents, The University Of Texas System |
Methods of enhancing immune induction involving mda-7
|
US6904823B2
(en)
|
2002-04-03 |
2005-06-14 |
Immersion Corporation |
Haptic shifting devices
|
US7332469B2
(en)
|
2002-04-05 |
2008-02-19 |
Board Of Regents The University Of Texas System |
Intrapleural single-chain urokinase alone or complexed to its soluble receptor protects against pleural adhesions
|
JP5570677B2
(en)
|
2002-04-25 |
2014-08-13 |
シャイアー ヒューマン ジェネティック セラピーズ インコーポレイテッド |
Treatment of α-galactosidase A deficiency
|
ES2326217T3
(en)
*
|
2002-04-26 |
2009-10-05 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
IMPROVED CHEMERIC GLICOPROTEINS AND PSEUDOTIPATED LENTIVIRAL VECTORS.
|
US20040025420A1
(en)
*
|
2002-05-09 |
2004-02-12 |
Peter M. Wild |
Injection needle for injecting woody plants
|
US6942638B1
(en)
*
|
2002-05-30 |
2005-09-13 |
Kerry Quinn |
Needleless injector and ampule system
|
WO2003101307A1
(en)
|
2002-05-31 |
2003-12-11 |
Vidacare Corporation |
Apparatus and method to access bone marrow
|
US11298202B2
(en)
|
2002-05-31 |
2022-04-12 |
Teleflex Life Sciences Limited |
Biopsy devices and related methods
|
US8641715B2
(en)
*
|
2002-05-31 |
2014-02-04 |
Vidacare Corporation |
Manual intraosseous device
|
US9314228B2
(en)
|
2002-05-31 |
2016-04-19 |
Vidacare LLC |
Apparatus and method for accessing the bone marrow
|
US8690791B2
(en)
|
2002-05-31 |
2014-04-08 |
Vidacare Corporation |
Apparatus and method to access the bone marrow
|
US9072543B2
(en)
|
2002-05-31 |
2015-07-07 |
Vidacare LLC |
Vascular access kits and methods
|
US10973532B2
(en)
|
2002-05-31 |
2021-04-13 |
Teleflex Life Sciences Limited |
Powered drivers, intraosseous devices and methods to access bone marrow
|
US11337728B2
(en)
|
2002-05-31 |
2022-05-24 |
Teleflex Life Sciences Limited |
Powered drivers, intraosseous devices and methods to access bone marrow
|
US8668698B2
(en)
|
2002-05-31 |
2014-03-11 |
Vidacare Corporation |
Assembly for coupling powered driver with intraosseous device
|
US10973545B2
(en)
|
2002-05-31 |
2021-04-13 |
Teleflex Life Sciences Limited |
Powered drivers, intraosseous devices and methods to access bone marrow
|
US8142365B2
(en)
*
|
2002-05-31 |
2012-03-27 |
Vidacare Corporation |
Apparatus and method for accessing the bone marrow of the sternum
|
US20070049945A1
(en)
|
2002-05-31 |
2007-03-01 |
Miller Larry J |
Apparatus and methods to install, support and/or monitor performance of intraosseous devices
|
US7811260B2
(en)
*
|
2002-05-31 |
2010-10-12 |
Vidacare Corporation |
Apparatus and method to inject fluids into bone marrow and other target sites
|
US9451968B2
(en)
*
|
2002-05-31 |
2016-09-27 |
Vidacare LLC |
Powered drivers, intraosseous devices and methods to access bone marrow
|
US7850620B2
(en)
*
|
2002-05-31 |
2010-12-14 |
Vidacare Corporation |
Biopsy devices and related methods
|
US7951089B2
(en)
|
2002-05-31 |
2011-05-31 |
Vidacare Corporation |
Apparatus and methods to harvest bone and bone marrow
|
AU2003247707A1
(en)
*
|
2002-07-03 |
2004-01-23 |
Peter M. Wild |
Plant injection method and apparatus
|
AU2003258168B2
(en)
|
2002-08-12 |
2009-10-29 |
Sillajen Biotherapeutics, Inc. |
Methods and compositions concerning poxviruses and cancer
|
US8917234B2
(en)
|
2002-10-15 |
2014-12-23 |
Immersion Corporation |
Products and processes for providing force sensations in a user interface
|
KR20050075373A
(en)
*
|
2002-11-01 |
2005-07-20 |
앤태어스 파머, 인코퍼레이티드 |
Administration of insulin by jet injection
|
AU2003288686A1
(en)
*
|
2002-11-22 |
2004-06-18 |
Institut Clayton De La Recherche |
Compositions and systems for the regulation of genes
|
US20040180419A1
(en)
|
2003-01-31 |
2004-09-16 |
Mount Sinai School Of Medicine Of New York University |
Combination therapy for treating protein deficiency disorders
|
CN1759122B
(en)
*
|
2003-03-03 |
2012-06-13 |
得克萨斯州大学系统董事会 |
Methods and compositions involving MDA-7
|
US6802455B1
(en)
*
|
2003-03-26 |
2004-10-12 |
Willie V. Evans |
Atomizer
|
FR2853837B1
(en)
*
|
2003-04-16 |
2006-01-13 |
Crossject |
DEVICE FOR CONNECTING AN ACTIVE PRINCIPLE RESERVOIR TO AN INJECTION NOZZLE IN A DEVICE FOR INJECTING SAID ACTIVE PRINCIPLE
|
CA2525017A1
(en)
*
|
2003-05-09 |
2004-12-23 |
Anges Mg, Inc. |
Needleless syringe having medical agent accommodated therein
|
EP1664322B1
(en)
|
2003-05-22 |
2013-07-10 |
Fraunhofer USA, Inc. |
Recombinant carrier molecule for expression, delivery and purification of target polypeptides
|
US9504477B2
(en)
|
2003-05-30 |
2016-11-29 |
Vidacare LLC |
Powered driver
|
WO2004111819A1
(en)
|
2003-06-09 |
2004-12-23 |
Immersion Corporation |
Interactive gaming systems with haptic feedback
|
HU225252B1
(en)
*
|
2003-08-21 |
2006-08-28 |
S Istvan Lindmayer |
Needleless injection apparatus
|
WO2005034949A1
(en)
*
|
2003-09-09 |
2005-04-21 |
University Of Florida |
Desferrithiocin derivatives and their use as iron chelators
|
US8034790B2
(en)
*
|
2003-12-01 |
2011-10-11 |
Introgen Therapeutics |
Use of MDA-7 to inhibit pathogenic infectious organisms
|
ES2607206T3
(en)
*
|
2004-01-26 |
2017-03-29 |
Vidacare LLC |
Manual interosseous device
|
WO2005070483A1
(en)
*
|
2004-01-26 |
2005-08-04 |
The Medical House Plc |
Needle-free injection device
|
US7815642B2
(en)
*
|
2004-01-26 |
2010-10-19 |
Vidacare Corporation |
Impact-driven intraosseous needle
|
US20070281041A1
(en)
*
|
2004-03-02 |
2007-12-06 |
Introgen Therapeutics, Inc. |
Compositions and Methods Involving MDA-7 for the Treatment of Cancer
|
DE102004017970A1
(en)
*
|
2004-04-12 |
2005-10-27 |
Leica Microsystems (Schweiz) Ag |
Stand, especially for surgical microscopes, with a force storage element
|
DE102004017971A1
(en)
*
|
2004-04-12 |
2005-10-27 |
Leica Microsystems (Schweiz) Ag |
Stand, especially for surgical microscopes, with a force storage element
|
DE102005018305A1
(en)
*
|
2004-05-25 |
2005-12-22 |
Tecpharma Licensing Ag |
Dosing unit comprises a dose-adjusting unit, which is rotated to adjust the dose, and a graduated scale
|
GB2414775B
(en)
*
|
2004-05-28 |
2008-05-21 |
Cilag Ag Int |
Releasable coupling and injection device
|
GB2414405B
(en)
*
|
2004-05-28 |
2009-01-14 |
Cilag Ag Int |
Injection device
|
GB2414402B
(en)
*
|
2004-05-28 |
2009-04-22 |
Cilag Ag Int |
Injection device
|
GB2414409B
(en)
*
|
2004-05-28 |
2009-11-18 |
Cilag Ag Int |
Injection device
|
US7717874B2
(en)
*
|
2004-05-28 |
2010-05-18 |
Bioject, Inc. |
Needle-free injection system
|
GB2414400B
(en)
*
|
2004-05-28 |
2009-01-14 |
Cilag Ag Int |
Injection device
|
GB2414404B
(en)
|
2004-05-28 |
2009-06-03 |
Cilag Ag Int |
Injection device
|
GB2414406B
(en)
|
2004-05-28 |
2009-03-18 |
Cilag Ag Int |
Injection device
|
GB2414401B
(en)
|
2004-05-28 |
2009-06-17 |
Cilag Ag Int |
Injection device
|
GB2414403B
(en)
*
|
2004-05-28 |
2009-01-07 |
Cilag Ag Int |
Injection device
|
GB2414399B
(en)
*
|
2004-05-28 |
2008-12-31 |
Cilag Ag Int |
Injection device
|
US20060190022A1
(en)
*
|
2004-07-14 |
2006-08-24 |
By-Pass, Inc. |
Material delivery system
|
US7615041B2
(en)
|
2004-07-29 |
2009-11-10 |
Boston Scientific Scimed, Inc. |
Vial adaptor
|
JP4059238B2
(en)
*
|
2004-09-16 |
2008-03-12 |
ソニー株式会社 |
Digital signal processing apparatus and digital signal processing method
|
JP2008513409A
(en)
|
2004-09-22 |
2008-05-01 |
グラクソスミスクライン バイオロジカルズ ソシエテ アノニム |
Immunogenic composition
|
US20060089594A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Sergio Landau |
Needle-free injection device
|
US20060089593A1
(en)
*
|
2004-10-26 |
2006-04-27 |
Sergio Landau |
Needle-free injection device for individual users
|
US9492400B2
(en)
*
|
2004-11-04 |
2016-11-15 |
Massachusetts Institute Of Technology |
Coated controlled release polymer particles as efficient oral delivery vehicles for biopharmaceuticals
|
CA2586115C
(en)
|
2004-11-05 |
2013-04-23 |
Icu Medical, Inc. |
Medical connector for having high flow rate characteristics
|
US8998848B2
(en)
*
|
2004-11-12 |
2015-04-07 |
Vidacare LLC |
Intraosseous device and methods for accessing bone marrow in the sternum and other target areas
|
JP4960252B2
(en)
|
2004-11-22 |
2012-06-27 |
インテリジェクト,インコーポレイテッド |
Device, system and method for drug delivery
|
WO2006058426A1
(en)
*
|
2004-12-01 |
2006-06-08 |
Wlt Distributors Inc. |
Needle-free injector
|
JP4948422B2
(en)
|
2005-02-01 |
2012-06-06 |
インテリジェクト,インコーポレイテッド |
Drug delivery apparatus, system and method
|
GB2422784A
(en)
*
|
2005-02-07 |
2006-08-09 |
Caretek Medical Ltd |
Disposable assembly comprising a needle or stylet
|
WO2006086798A2
(en)
*
|
2005-02-08 |
2006-08-17 |
Board Of Regents, The University Of Texas System |
Compositions and methods involving mda-7 for the treatment of cancer
|
EP1861120B1
(en)
|
2005-03-23 |
2016-05-25 |
GlaxoSmithKline Biologicals S.A. |
Use of an influenza virus and an oil-in-water emulsion adjuvant to induce cd4 t-cell and/or improved b-memory cell response
|
WO2006107626A1
(en)
|
2005-04-04 |
2006-10-12 |
University Of Florida Research Foundation, Inc. |
Desferrithiocin polyether analogues
|
GB2424837B
(en)
*
|
2005-04-06 |
2010-10-06 |
Cilag Ag Int |
Injection device
|
GB2427826B
(en)
*
|
2005-04-06 |
2010-08-25 |
Cilag Ag Int |
Injection device comprising a locking mechanism associated with integrally formed biasing means
|
GB2425062B
(en)
*
|
2005-04-06 |
2010-07-21 |
Cilag Ag Int |
Injection device
|
GB2424835B
(en)
*
|
2005-04-06 |
2010-06-09 |
Cilag Ag Int |
Injection device (modified trigger)
|
GB2424836B
(en)
*
|
2005-04-06 |
2010-09-22 |
Cilag Ag Int |
Injection device (bayonet cap removal)
|
GB2424838B
(en)
*
|
2005-04-06 |
2011-02-23 |
Cilag Ag Int |
Injection device (adaptable drive)
|
US20070027428A1
(en)
*
|
2005-05-03 |
2007-02-01 |
Pharmajet, Inc. |
Vial system and method for needle-less injector
|
US7618393B2
(en)
|
2005-05-03 |
2009-11-17 |
Pharmajet, Inc. |
Needle-less injector and method of fluid delivery
|
US7699802B2
(en)
*
|
2005-05-03 |
2010-04-20 |
Pharmajet, Inc. |
Needle-less injector
|
EP2932982B1
(en)
|
2005-05-17 |
2018-10-03 |
Amicus Therapeutics, Inc. |
A method for the treatment of pompe disease using 1-deoxynojirimycin and derivatives
|
US20100119525A1
(en)
*
|
2005-08-01 |
2010-05-13 |
Mount Sinai Schoool Of Medicine Of New York University |
Method for extending longevity using npc1l1 antagonists
|
JP2009502207A
(en)
|
2005-08-03 |
2009-01-29 |
フラウンホーファー ユーエスエー, インコーポレイテッド |
Compositions and methods for the production of immunoglobulins
|
US8998881B2
(en)
*
|
2005-08-10 |
2015-04-07 |
Alza Corporation |
Method for delivering drugs to tissue under microjet propulsion
|
PL1759729T3
(en)
|
2005-08-30 |
2010-09-30 |
Cilag Gmbh Int |
Needle assembly for a prefilled syringe system
|
US9180149B2
(en)
|
2005-09-07 |
2015-11-10 |
Sillajen Biotherapeutics, Inc. |
Systemic treatment of metastatic and/or systemically-disseminated cancers using GM-CSF-expressing poxviruses
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
US20110098656A1
(en)
|
2005-09-27 |
2011-04-28 |
Burnell Rosie L |
Auto-injection device with needle protecting cap having outer and inner sleeves
|
US8672879B2
(en)
*
|
2005-10-13 |
2014-03-18 |
Argos Therapeutics, Inc. |
Devices, systems and related methods suitable for delivery of a liquid medicament stored at cryogenic temperatures
|
TWI457133B
(en)
|
2005-12-13 |
2014-10-21 |
Glaxosmithkline Biolog Sa |
Novel composition
|
WO2007070682A2
(en)
*
|
2005-12-15 |
2007-06-21 |
Massachusetts Institute Of Technology |
System for screening particles
|
DE102005062220B3
(en)
*
|
2005-12-20 |
2007-02-15 |
Primojex Gmbh |
System for needle-free or needle injection of fluid, e.g. medicament, comprises injection device connectable to needle attachment separable into cannula and adapter parts, allowing changing of needles
|
US7988660B2
(en)
*
|
2005-12-20 |
2011-08-02 |
Eli Lilly And Company |
Needle-free injection device
|
MY148141A
(en)
|
2005-12-22 |
2013-03-15 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB0607088D0
(en)
|
2006-04-07 |
2006-05-17 |
Glaxosmithkline Biolog Sa |
Vaccine
|
US20080161755A1
(en)
*
|
2006-01-27 |
2008-07-03 |
Bioject Inc. |
Needle-free injection device and priming system
|
WO2007092944A2
(en)
*
|
2006-02-08 |
2007-08-16 |
Introgen Therapeutics, Inc. |
Compositions and methods involving gene therapy and proteasome modulation
|
WO2008048344A2
(en)
*
|
2006-02-13 |
2008-04-24 |
Fraunhofer Usa, Inc. |
Bacillus anthracis antigens, vaccine compositions, and related methods
|
WO2007095320A2
(en)
*
|
2006-02-13 |
2007-08-23 |
Fraunhofer Usa, Inc. |
Hpv antigens, vaccine compositions, and related methods
|
JP2009526526A
(en)
*
|
2006-02-13 |
2009-07-23 |
フラウンホーファー ユーエスエー, インコーポレイテッド |
Influenza antigens, vaccine compositions, and related methods
|
US20090246142A1
(en)
*
|
2006-03-10 |
2009-10-01 |
Massachusetts Institute Of Technology |
Triggered Self-Assembly of Nanoparticles In Vivo
|
US7666912B2
(en)
|
2006-03-23 |
2010-02-23 |
Massachusetts Eye And Ear Infirmary |
Compositions and methods for reducing body fat
|
EP3141261A1
(en)
|
2006-03-30 |
2017-03-15 |
GlaxoSmithKline Biologicals S.A. |
Immunogenic composition
|
EP2007435B1
(en)
*
|
2006-03-31 |
2019-12-18 |
Massachusetts Institute Of Technology |
System for targeted delivery of therapeutic agents
|
WO2007120638A2
(en)
*
|
2006-04-12 |
2007-10-25 |
President And Fellows Of Harvard College |
Methods and compositions for modulating glycosylation
|
WO2007131013A1
(en)
|
2006-05-03 |
2007-11-15 |
Antares Pharma, Inc. |
Two-stage reconstituting injector
|
JP5630998B2
(en)
|
2006-05-15 |
2014-11-26 |
マサチューセッツ インスティテュート オブ テクノロジー |
Polymers for functional particles
|
WO2007137117A2
(en)
*
|
2006-05-17 |
2007-11-29 |
Massachusetts Institute Of Technology |
Aptamer-directed drug delivery
|
GB2438591B
(en)
*
|
2006-06-01 |
2011-07-13 |
Cilag Gmbh Int |
Injection device
|
GB2438590B
(en)
|
2006-06-01 |
2011-02-09 |
Cilag Gmbh Int |
Injection device
|
GB2438593B
(en)
|
2006-06-01 |
2011-03-30 |
Cilag Gmbh Int |
Injection device (cap removal feature)
|
EP2030015B1
(en)
|
2006-06-02 |
2016-02-17 |
President and Fellows of Harvard College |
Protein surface remodeling
|
EP2023981B1
(en)
*
|
2006-06-07 |
2020-01-22 |
Acushot Inc. |
Charging mechanism for a needle-free injector
|
US9381477B2
(en)
|
2006-06-23 |
2016-07-05 |
Massachusetts Institute Of Technology |
Microfluidic synthesis of organic nanoparticles
|
EP2035065B1
(en)
*
|
2006-06-28 |
2014-06-18 |
Perf-Action Technologies Ltd. |
Intradermal needle-less injection device
|
CN105727276A
(en)
|
2006-07-17 |
2016-07-06 |
葛兰素史密丝克莱恩生物有限公司 |
Influenza vaccine
|
US9115358B2
(en)
*
|
2006-08-11 |
2015-08-25 |
President And Fellows Of Harvard College |
Moenomycin biosynthesis-related compositions and methods of use thereof
|
JP2010501074A
(en)
*
|
2006-08-14 |
2010-01-14 |
マサチューセッツ・インスティテュート・オブ・テクノロジー |
Glycan data mining system
|
US20090269342A1
(en)
*
|
2006-08-14 |
2009-10-29 |
Massachusetts Institute Of Technology |
Hemagglutinin Polypeptides, and Reagents and Methods Relating Thereto
|
US8944069B2
(en)
|
2006-09-12 |
2015-02-03 |
Vidacare Corporation |
Assemblies for coupling intraosseous (IO) devices to powered drivers
|
EP2068743B1
(en)
|
2006-09-12 |
2017-03-15 |
Vidacare LLC |
Medical procedures trays, kits and related methods
|
EP2073728B1
(en)
|
2006-09-12 |
2018-11-07 |
Teleflex Medical Devices S.à.r.l. |
Biopsy device
|
ES2612955T3
(en)
|
2006-09-12 |
2017-05-19 |
Vidacare LLC |
Bone Marrow Aspiration Devices
|
EP2062116A2
(en)
|
2006-09-13 |
2009-05-27 |
Immersion Corporation |
Systems and methods for casino gaming haptics
|
ES2551892T3
(en)
|
2006-09-15 |
2015-11-24 |
Ottawa Health Research Institute |
Oncolytic rhabdovirus
|
US7547293B2
(en)
|
2006-10-06 |
2009-06-16 |
Bioject, Inc. |
Triggering mechanism for needle-free injector
|
JO3598B1
(en)
|
2006-10-10 |
2020-07-05 |
Infinity Discovery Inc |
Boronic acids and esters as inhibitors of fatty acid amide hydrolase
|
EA015817B1
(en)
|
2006-10-12 |
2011-12-30 |
Глаксосмитклайн Байолоджикалс С.А. |
Immunogenic composition comprising an oil in water emulsion adjuvant
|
SI2086582T1
(en)
|
2006-10-12 |
2013-02-28 |
Glaxosmithkline Biologicals S.A. |
Vaccine comprising an oil in water emulsion adjuvant
|
US7780201B2
(en)
|
2006-10-13 |
2010-08-24 |
Medela Holding Ag |
Tube connector with three part construction and latching component
|
JP5015258B2
(en)
|
2006-10-25 |
2012-08-29 |
アイシーユー・メディカル・インコーポレーテッド |
Medical connector
|
US8974410B2
(en)
|
2006-10-30 |
2015-03-10 |
Vidacare LLC |
Apparatus and methods to communicate fluids and/or support intraosseous devices
|
US20100303723A1
(en)
*
|
2006-11-20 |
2010-12-02 |
Massachusetts Institute Of Technology |
Drug delivery systems using fc fragments
|
KR20090106493A
(en)
|
2006-12-01 |
2009-10-09 |
안테리오스, 인코퍼레이티드 |
Micellar nanoparticles comprising botulinum toxin
|
AU2007333225B2
(en)
*
|
2006-12-08 |
2014-06-12 |
Massachusetts Institute Of Technology |
Delivery of nanoparticles and/or agents to cells
|
US20080140001A1
(en)
*
|
2006-12-12 |
2008-06-12 |
By-Pass Inc. |
Fluid Delivery Apparatus And Methods
|
DK2114873T3
(en)
|
2006-12-26 |
2013-05-13 |
Lantheus Medical Imaging Inc |
N- [3-BROMO-4- (3- [18F] FLUORPROPOXY) -BENZYL] -GUANIDINE FOR IMAGING HEART INNERVATION
|
CA2939778C
(en)
|
2007-01-31 |
2019-01-29 |
Dana-Farber Cancer Institute, Inc. |
Stabilized p53 peptides and uses thereof
|
US9217129B2
(en)
*
|
2007-02-09 |
2015-12-22 |
Massachusetts Institute Of Technology |
Oscillating cell culture bioreactor
|
US8118814B2
(en)
*
|
2007-02-14 |
2012-02-21 |
Depuy Mitek Inc. |
Implement for orientating a tool, particularly useful in surgical tools for harvesting and implanting bone plugs to repair damaged bone tissue
|
DE102007008597A1
(en)
|
2007-02-19 |
2008-08-21 |
Primojex Gmbh |
Fluid injecting system for use through or into epidermis or corium of human skin, has mounting device protecting ampoule body of syringe, and injection device axially adjusting ampoule piston corresponding to given pressure profile
|
US7744563B2
(en)
*
|
2007-02-23 |
2010-06-29 |
Bioject, Inc. |
Needle-free injection devices and drug delivery systems therefor
|
KR20080084528A
(en)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
Oncolytic vaccinia virus cancer therapy
|
CN104003955A
(en)
|
2007-03-15 |
2014-08-27 |
佛罗里达大学研究基金公司 |
Desferrithiocin polyether analogues
|
US7960139B2
(en)
|
2007-03-23 |
2011-06-14 |
Academia Sinica |
Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells
|
US8592377B2
(en)
|
2007-03-28 |
2013-11-26 |
President And Fellows Of Harvard College |
Stitched polypeptides
|
WO2008124634A1
(en)
|
2007-04-04 |
2008-10-16 |
Massachusetts Institute Of Technology |
Polymer-encapsulated reverse micelles
|
EP2144600A4
(en)
|
2007-04-04 |
2011-03-16 |
Massachusetts Inst Technology |
Poly (amino acid) targeting moieties
|
BRPI0810865A2
(en)
*
|
2007-04-28 |
2017-05-09 |
Fraunhofer Usa Inc |
trypanosome antigens, vaccine compositions, and related methods
|
US20100191215A1
(en)
*
|
2007-06-12 |
2010-07-29 |
By-Pass ,Inc. |
Pressure pulse actuating device for delivery systems
|
WO2008152052A1
(en)
*
|
2007-06-14 |
2008-12-18 |
Berna Biotech Ag |
Intradermal influenza vaccine
|
WO2008156676A1
(en)
|
2007-06-15 |
2008-12-24 |
President And Fellows Of Harvard College |
Methods and compositions for detecting and modulating o-glycosylation
|
EP2167120A2
(en)
|
2007-06-26 |
2010-03-31 |
GlaxoSmithKline Biologicals S.A. |
Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
|
CA2692933C
(en)
|
2007-07-11 |
2016-10-18 |
Fraunhofer Usa, Inc. |
Yersinia pestis antigens, vaccine compositions, and related methods
|
CA2696764A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Fraunhofer Usa, Inc. |
Prophylactic and therapeutic influenza vaccines, antigens, compositions, and methods
|
CA2704933A1
(en)
|
2007-08-21 |
2009-02-26 |
Yukon Medical, Llc |
Vial access and injection system
|
US8604004B2
(en)
*
|
2007-10-04 |
2013-12-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
CN101903058B
(en)
*
|
2007-10-10 |
2013-03-20 |
Shl集团有限责任公司 |
Medical delivery device
|
MX2010003642A
(en)
|
2007-10-12 |
2010-08-09 |
Massachusetts Inst Technology |
Vaccine nanotechnology.
|
US8002753B2
(en)
*
|
2007-12-21 |
2011-08-23 |
Nordson Corporation |
Self-contained pressurized injection device
|
AU2009204345A1
(en)
*
|
2008-01-03 |
2009-07-16 |
Massachusetts Institute Of Technology |
Decoy influenza therapies
|
US8193182B2
(en)
|
2008-01-04 |
2012-06-05 |
Intellikine, Inc. |
Substituted isoquinolin-1(2H)-ones, and methods of use thereof
|
DE102008008023A1
(en)
|
2008-02-04 |
2009-08-13 |
Primojex Gmbh |
System for injecting a fluid through or into the human skin
|
US9486292B2
(en)
|
2008-02-14 |
2016-11-08 |
Immersion Corporation |
Systems and methods for real-time winding analysis for knot detection
|
US20110288521A1
(en)
*
|
2008-03-07 |
2011-11-24 |
Pharma Jet ,Inc. |
Intradermal injector and uses thereof
|
EP2268342B1
(en)
|
2008-03-10 |
2015-09-16 |
Antares Pharma, Inc. |
Injector safety device
|
US9117870B2
(en)
*
|
2008-03-27 |
2015-08-25 |
Lam Research Corporation |
High throughput cleaner chamber
|
US8936571B2
(en)
*
|
2008-03-31 |
2015-01-20 |
Laura Devega |
Illuminated syringe
|
EP2271387B1
(en)
*
|
2008-04-01 |
2016-06-15 |
Yukon Medical, LLC |
Dual container fluid transfer device
|
TW201000107A
(en)
*
|
2008-04-09 |
2010-01-01 |
Infinity Pharmaceuticals Inc |
Inhibitors of fatty acid amide hydrolase
|
ES2553113T3
(en)
|
2008-04-16 |
2015-12-04 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
US20110112040A1
(en)
*
|
2008-04-28 |
2011-05-12 |
President And Fellows Of Harvard College |
Supercharged proteins for cell penetration
|
US8052645B2
(en)
|
2008-07-23 |
2011-11-08 |
Avant Medical Corp. |
System and method for an injection using a syringe needle
|
CA3142745A1
(en)
|
2008-05-20 |
2009-11-26 |
Avant Medical Corp. |
Autoinjector system
|
US8177749B2
(en)
|
2008-05-20 |
2012-05-15 |
Avant Medical Corp. |
Cassette for a hidden injection needle
|
GB2461086B
(en)
*
|
2008-06-19 |
2012-12-05 |
Cilag Gmbh Int |
Injection device
|
GB2461085B
(en)
*
|
2008-06-19 |
2012-08-29 |
Cilag Gmbh Int |
Injection device
|
GB2461089B
(en)
*
|
2008-06-19 |
2012-09-19 |
Cilag Gmbh Int |
Injection device
|
GB2461087B
(en)
*
|
2008-06-19 |
2012-09-26 |
Cilag Gmbh Int |
Injection device
|
GB2461088B
(en)
*
|
2008-06-19 |
2012-09-26 |
Cilag Gmbh Int |
Injection device
|
GB2461084B
(en)
*
|
2008-06-19 |
2012-09-26 |
Cilag Gmbh Int |
Fluid transfer assembly
|
BRPI0914630A2
(en)
|
2008-06-26 |
2019-09-24 |
Anterios Inc |
dermal release
|
JP5986745B2
(en)
|
2008-07-15 |
2016-09-06 |
アカデミア シニカAcademia Sinica |
Glycan arrays on PTFE-like aluminum-coated glass slides and related methods
|
EP2356139A4
(en)
|
2008-07-23 |
2013-01-09 |
Harvard College |
Ligation of stapled polypeptides
|
EP2317994A4
(en)
*
|
2008-07-23 |
2012-09-12 |
Massachusetts Inst Technology |
Activation of histone deacetylase 1 (hdac1) protects against dna damage and increases neuronal survival
|
US20100021472A1
(en)
*
|
2008-07-25 |
2010-01-28 |
Geetha Srikrishna |
Methods for diagnosing and treating cancer
|
US8734803B2
(en)
|
2008-09-28 |
2014-05-27 |
Ibio Inc. |
Humanized neuraminidase antibody and methods of use thereof
|
US8277812B2
(en)
*
|
2008-10-12 |
2012-10-02 |
Massachusetts Institute Of Technology |
Immunonanotherapeutics that provide IgG humoral response without T-cell antigen
|
US8343497B2
(en)
|
2008-10-12 |
2013-01-01 |
The Brigham And Women's Hospital, Inc. |
Targeting of antigen presenting cells with immunonanotherapeutics
|
US8343498B2
(en)
|
2008-10-12 |
2013-01-01 |
Massachusetts Institute Of Technology |
Adjuvant incorporation in immunonanotherapeutics
|
US8591905B2
(en)
|
2008-10-12 |
2013-11-26 |
The Brigham And Women's Hospital, Inc. |
Nicotine immunonanotherapeutics
|
EP2376089B1
(en)
|
2008-11-17 |
2018-03-14 |
The Regents of the University of Michigan |
Cancer vaccine compositions and methods of using the same
|
WO2010077806A1
(en)
|
2008-12-15 |
2010-07-08 |
Greenlight Biosciences, Inc. |
Methods for control of flux in metabolic pathways
|
JP5905724B2
(en)
*
|
2008-12-22 |
2016-04-20 |
グリーンライト バイオサイエンシーズ インコーポレーテッドGreenlight Biosciences,Inc. |
Compositions and methods for the preparation of compounds
|
US8454579B2
(en)
|
2009-03-25 |
2013-06-04 |
Icu Medical, Inc. |
Medical connector with automatic valves and volume regulator
|
US20100252373A1
(en)
*
|
2009-04-02 |
2010-10-07 |
Innovative Office Products, Inc. |
Friction device for a spring cylinder
|
CA2757622A1
(en)
|
2009-04-07 |
2010-10-14 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of fatty acid amide hydrolase
|
JP2012523424A
(en)
|
2009-04-07 |
2012-10-04 |
インフイニトイ プハルマセウトイカルス インコーポレイテッド |
Inhibitors of fatty acid amide hydrolase
|
ES2564093T3
(en)
|
2009-04-09 |
2016-03-17 |
Amicus Therapeutics, Inc. |
Methods to prevent and / or treat lysosomal storage disorders
|
JP5685579B2
(en)
|
2009-04-14 |
2015-03-18 |
ユーコン・メディカル,リミテッド・ライアビリティ・カンパニー |
Fluid transfer device
|
EP2424877A4
(en)
|
2009-04-28 |
2013-01-02 |
Harvard College |
Supercharged proteins for cell penetration
|
US8765735B2
(en)
*
|
2009-05-18 |
2014-07-01 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US8927551B2
(en)
*
|
2009-05-18 |
2015-01-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9149465B2
(en)
*
|
2009-05-18 |
2015-10-06 |
Infinity Pharmaceuticals, Inc. |
Isoxazolines as inhibitors of fatty acid amide hydrolase
|
US9104791B2
(en)
|
2009-05-28 |
2015-08-11 |
Immersion Corporation |
Systems and methods for editing a model of a physical system for a simulation
|
JP2012528858A
(en)
|
2009-06-01 |
2012-11-15 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
O-GlcNAc transferase inhibitor and use thereof
|
US9163330B2
(en)
|
2009-07-13 |
2015-10-20 |
President And Fellows Of Harvard College |
Bifunctional stapled polypeptides and uses thereof
|
GB0913681D0
(en)
|
2009-08-05 |
2009-09-16 |
Glaxosmithkline Biolog Sa |
Immunogenic composition
|
DK2477499T3
(en)
|
2009-09-14 |
2018-06-06 |
Sillajen Biotherapeutics Inc |
COMBINATION CANCER THERAPY WITH ONCOLYTIC VACCINIA VIRUS
|
EP2480565A4
(en)
|
2009-09-22 |
2014-01-01 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles
|
CA2776144C
(en)
|
2009-09-29 |
2020-10-27 |
Fraunhofer Usa, Inc. |
Influenza hemagglutinin antibodies, compositions, and related methods
|
CN105367485B
(en)
|
2009-10-19 |
2018-04-17 |
阿米库斯治疗学公司 |
For preventing and/or treating the novel composition of central nervous system neurodegenerative disorders
|
HUE028129T2
(en)
|
2009-10-19 |
2016-11-28 |
Amicus Therapeutics Inc |
Novel compositions for preventing and/or treating lysosomal storage disorders
|
US11377485B2
(en)
|
2009-12-02 |
2022-07-05 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
US10087236B2
(en)
|
2009-12-02 |
2018-10-02 |
Academia Sinica |
Methods for modifying human antibodies by glycan engineering
|
WO2011070440A2
(en)
|
2009-12-10 |
2011-06-16 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
EP2519517B1
(en)
|
2009-12-29 |
2015-03-25 |
Dana-Farber Cancer Institute, Inc. |
Type ii raf kinase inhibitors
|
US8637456B2
(en)
|
2010-01-27 |
2014-01-28 |
Massachusetts Institute Of Technology |
Engineered polypeptide agents for targeted broad spectrum influenza neutralization
|
CN102834401B
(en)
|
2010-02-03 |
2016-08-24 |
无限药品股份有限公司 |
Inhibitors of fatty acid amide hydrolase
|
EA025443B1
(en)
|
2010-03-08 |
2016-12-30 |
Слоан-Кеттеринг Институт Фор Кэнсер |
USE OF GRANATICIN B AS Cdc7 KINASE INHIBITOR
|
GB201003920D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Method of treatment
|
GB201003922D0
(en)
|
2010-03-09 |
2010-04-21 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
US9102697B2
(en)
|
2010-03-22 |
2015-08-11 |
President And Fellows Of Harvard College |
Trioxacarcins and uses thereof
|
USD644731S1
(en)
|
2010-03-23 |
2011-09-06 |
Icu Medical, Inc. |
Medical connector
|
WO2011130332A1
(en)
|
2010-04-12 |
2011-10-20 |
Academia Sinica |
Glycan arrays for high throughput screening of viruses
|
EP2566853B1
(en)
|
2010-05-05 |
2017-01-25 |
Infinity Pharmaceuticals, Inc. |
Tetrazolones as inhibitors of fatty acid synthase
|
US8450350B2
(en)
|
2010-05-05 |
2013-05-28 |
Infinity Pharmaceuticals, Inc. |
Triazoles as inhibitors of fatty acid synthase
|
DK2566953T3
(en)
|
2010-05-07 |
2019-04-15 |
Greenlight Biosciences Inc |
METHODS OF MANAGING THE POWER BY METABOLIC ROADS USING ENZYMOUS LOCATION
|
TWI606842B
(en)
|
2010-05-11 |
2017-12-01 |
藍瑟斯醫學影像公司 |
Compositions, methods and systems for the synthesis and use of imaging agents
|
US8758306B2
(en)
|
2010-05-17 |
2014-06-24 |
Icu Medical, Inc. |
Medical connectors and methods of use
|
USD655017S1
(en)
|
2010-06-17 |
2012-02-28 |
Yukon Medical, Llc |
Shroud
|
ES2664872T3
(en)
|
2010-06-18 |
2018-04-23 |
Taiho Pharmaceutical Co., Ltd |
PRPK-TPRKB modulators and their uses
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
SI2603600T1
(en)
|
2010-08-13 |
2019-04-30 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
DK3219796T3
(en)
|
2010-08-31 |
2020-12-21 |
Greenlight Biosciences Inc |
PROCEDURES FOR MONITORING FLOW IN METABOLIC REACTIONS BY PROTEASE MANIPULATION
|
AU2011305371B2
(en)
|
2010-09-21 |
2015-05-21 |
Massachusetts Institute Of Technology |
Human-adapted HA polypeptides, vaccines, and influenza treatment
|
US8957026B2
(en)
|
2010-09-22 |
2015-02-17 |
President And Fellows Of Harvard College |
Beta-catenin targeting peptides and uses thereof
|
DK3590949T3
(en)
|
2010-10-01 |
2022-07-11 |
Modernatx Inc |
RIBONUCLEIC ACIDS CONTAINING N1-METHYL-PSEUDOURACIL AND USE THEREOF
|
SG189236A1
(en)
|
2010-10-04 |
2013-05-31 |
Massachusetts Inst Technology |
Hemagglutinin polypeptides, and reagents and methods relating thereto
|
US8901133B2
(en)
|
2010-11-10 |
2014-12-02 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
TWI503137B
(en)
*
|
2010-11-19 |
2015-10-11 |
Msd Consumer Care Inc |
Click pen applicator device
|
KR101224581B1
(en)
|
2010-12-10 |
2013-01-21 |
주식회사 모리스 |
Cap with Automatic Sealing Structure in Tube Container
|
GB201021716D0
(en)
*
|
2010-12-22 |
2011-02-02 |
Owen Mumford Ltd |
Autoinjectors
|
CA2824277C
(en)
|
2011-01-04 |
2021-08-31 |
Jennerex, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
PE20141303A1
(en)
|
2011-01-10 |
2014-10-01 |
Infinity Pharmaceuticals Inc |
PROCEDURE FOR PREPARING ISOQUINOLINONES AND SOLID FORMS OF ISOQUINOLINONES
|
CA2822908A1
(en)
*
|
2011-01-10 |
2012-07-19 |
Zogenix, Inc. |
Improved needle free injectors
|
CA2824317C
(en)
|
2011-01-19 |
2014-12-16 |
Terakine Therapeutics, Inc. |
Uses of certain f-series prostaglandin analogs for treating diabetes and dyslipidemia
|
KR20140005998A
(en)
|
2011-01-24 |
2014-01-15 |
안테리오스, 인코퍼레이티드 |
Nanoparticle compositions, formulations thereof, and uses therefor
|
BR112013018918A2
(en)
|
2011-01-24 |
2016-10-04 |
Anterios Inc |
nanoparticle compositions
|
KR20140003573A
(en)
|
2011-01-24 |
2014-01-09 |
안테리오스, 인코퍼레이티드 |
Oil compositions
|
SG193258A1
(en)
|
2011-03-03 |
2013-10-30 |
Tersus Pharmaceuticals Llc |
COMPOSITIONS AND METHODS COMPRISING C16:1n7-PALMITOLEATE
|
GB201103836D0
(en)
|
2011-03-07 |
2011-04-20 |
Glaxosmithkline Biolog Sa |
Conjugation process
|
EP2691396B1
(en)
|
2011-03-30 |
2016-08-10 |
Brown University |
Enopeptins, uses thereof, and methods of synthesis thereto
|
CA2831613A1
(en)
|
2011-03-31 |
2012-10-04 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
ES2597735T3
(en)
*
|
2011-04-04 |
2017-01-20 |
Idee International R&D Inc. |
Needleless Injector Rod Assembly
|
CA2833850A1
(en)
*
|
2011-04-19 |
2012-10-26 |
Invisiderm, Llc |
Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
|
JP6038884B2
(en)
|
2011-04-20 |
2016-12-07 |
アムゲン・インコーポレーテッド |
Automatic injection device
|
US20140072622A1
(en)
|
2011-05-17 |
2014-03-13 |
Glaxosmithkline Biologicals S.A. |
Vaccine against streptococcus pneumoniae
|
WO2012167382A1
(en)
|
2011-06-08 |
2012-12-13 |
Children's Hospital Of Eastern Ontario Research Institute Inc. |
Compositions and methods for glioblastoma treatment
|
US9845327B2
(en)
|
2011-06-22 |
2017-12-19 |
The General Hospital Corporation |
Treatment of proteinopathies
|
JP6027610B2
(en)
|
2011-07-19 |
2016-11-16 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Heterocyclic compounds and uses thereof
|
CA2842190A1
(en)
|
2011-07-19 |
2013-01-24 |
Infinity Pharmaceuticals Inc. |
Heterocyclic compounds and uses thereof
|
EP2734510B8
(en)
|
2011-07-22 |
2019-05-29 |
Massachusetts Institute of Technology |
Activators of class i histone deacetylases (hdacs) and uses thereof
|
US9408972B2
(en)
|
2011-08-02 |
2016-08-09 |
Pharmajet, Inc. |
Needle-free injection device
|
US8785470B2
(en)
|
2011-08-29 |
2014-07-22 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
USD681230S1
(en)
|
2011-09-08 |
2013-04-30 |
Yukon Medical, Llc |
Shroud
|
CA2846893A1
(en)
|
2011-09-09 |
2013-03-14 |
Greenlight Biosciences, Inc. |
Cell-free preparation of carbapenems
|
JP6174026B2
(en)
|
2011-09-09 |
2017-08-02 |
ランセウス メディカル イメージング, インコーポレイテッド |
Compositions, methods and systems for the synthesis and use of contrast agents
|
EP3384938A1
(en)
|
2011-09-12 |
2018-10-10 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2013049332A1
(en)
|
2011-09-29 |
2013-04-04 |
Infinity Pharmaceuticals, Inc. |
Inhibitors of monoacylglycerol lipase and methods of their use
|
SG10201602654SA
(en)
|
2011-10-03 |
2016-05-30 |
Moderna Therapeutics Inc |
Modified nucleosides,nucleotides,and nucleic acids,and uses thereof
|
US20130096170A1
(en)
|
2011-10-14 |
2013-04-18 |
Hospira, Inc. |
Methods of treating pediatric patients using dexmedetomidine
|
BR112014009418A2
(en)
|
2011-10-18 |
2017-04-18 |
Aileron Therapeutics Inc |
peptidomimetic macrocycles
|
JP6106685B2
(en)
|
2011-11-17 |
2017-04-05 |
ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド |
Inhibitors of C-JUN-N-terminal kinase (JNK)
|
GB201119999D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
GB201120000D0
(en)
|
2011-11-20 |
2012-01-04 |
Glaxosmithkline Biolog Sa |
Vaccine
|
EP2790755B1
(en)
|
2011-12-13 |
2021-08-11 |
Pharmajet Inc. |
Needle-free intradermal injection device
|
US20140343110A1
(en)
|
2011-12-16 |
2014-11-20 |
University Of Florida Research Foundation, Inc. |
Uses of 4'-desferrithiocin analogs
|
WO2013090648A1
(en)
|
2011-12-16 |
2013-06-20 |
modeRNA Therapeutics |
Modified nucleoside, nucleotide, and nucleic acid compositions
|
US8426471B1
(en)
|
2011-12-19 |
2013-04-23 |
Topokine Therapeutics, Inc. |
Methods and compositions for reducing body fat and adipocytes
|
US8242158B1
(en)
|
2012-01-04 |
2012-08-14 |
Hospira, Inc. |
Dexmedetomidine premix formulation
|
US10130800B2
(en)
|
2012-01-27 |
2018-11-20 |
Invisiderm, Llc |
Method of producing substances with supersaturated gas, transdermal delivery device thereof, and uses thereof
|
CA2862038C
(en)
|
2012-02-15 |
2021-05-25 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US8987414B2
(en)
|
2012-02-15 |
2015-03-24 |
Aileron Therapeutics, Inc. |
Triazole-crosslinked and thioether-crosslinked peptidomimetic macrocycles
|
EP4327849A3
(en)
|
2012-03-06 |
2024-04-24 |
Antares Pharma, Inc. |
Prefilled syringe with breakaway force feature
|
WO2013142871A1
(en)
*
|
2012-03-23 |
2013-09-26 |
Ddps Global, Llc |
Compression spring and pump for dispensing fluid
|
MX354127B
(en)
|
2012-03-27 |
2018-02-14 |
Amicus Therapeutics Inc |
Novel compounds for preventing and/or treating lysosomal storage disorders and/or degenerative disorders of the central nervous system.
|
WO2013152277A2
(en)
|
2012-04-06 |
2013-10-10 |
President And Fellows Of Harvard College |
Moenomycin analogs, methods of synthesis, and uses thereof
|
EP4186545A1
(en)
|
2012-04-06 |
2023-05-31 |
Antares Pharma, Inc. |
Needle assisted jet injection administration of testosterone compositions
|
EP2850090B1
(en)
|
2012-04-06 |
2018-10-03 |
President and Fellows of Harvard College |
Chemoenzymatic methods for synthesizing moenomycin analogs
|
EP2850091A1
(en)
|
2012-04-06 |
2015-03-25 |
President and Fellows of Harvard College |
Methods and compounds for identifying glycosyltransferase inhibitors
|
US8940742B2
(en)
|
2012-04-10 |
2015-01-27 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
US10130714B2
(en)
|
2012-04-14 |
2018-11-20 |
Academia Sinica |
Enhanced anti-influenza agents conjugated with anti-inflammatory activity
|
USD808010S1
(en)
|
2012-04-20 |
2018-01-16 |
Amgen Inc. |
Injection device
|
USD898908S1
(en)
|
2012-04-20 |
2020-10-13 |
Amgen Inc. |
Pharmaceutical product cassette for an injection device
|
WO2013163176A1
(en)
|
2012-04-23 |
2013-10-31 |
Allertein Therapeutics, Llc |
Nanoparticles for treatment of allergy
|
SG10201807059QA
(en)
|
2012-05-10 |
2018-09-27 |
Massachusetts Inst Technology |
Agents for influenza neutralization
|
USD769444S1
(en)
|
2012-06-28 |
2016-10-18 |
Yukon Medical, Llc |
Adapter device
|
UA114108C2
(en)
|
2012-07-10 |
2017-04-25 |
Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем |
Monoclonal antibodies for use in diagnosis and therapy of cancers and autoimmune disease
|
WO2014011958A1
(en)
*
|
2012-07-12 |
2014-01-16 |
Antares Pharma, Inc. |
Liquid-transfer adapter beveled spike
|
CA2879939A1
(en)
|
2012-08-06 |
2014-02-13 |
Glaxosmithkline Biologicals S.A. |
Novel method
|
US20140037680A1
(en)
|
2012-08-06 |
2014-02-06 |
Glaxosmithkline Biologicals, S.A. |
Novel method
|
AU2013203000B9
(en)
|
2012-08-10 |
2017-02-02 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
US9914956B2
(en)
|
2012-08-18 |
2018-03-13 |
Academia Sinica |
Cell-permeable probes for identification and imaging of sialidases
|
PT2920197T
(en)
|
2012-09-26 |
2021-06-11 |
Harvard College |
Proline-locked stapled peptides and uses thereof
|
US20150225471A1
(en)
|
2012-10-01 |
2015-08-13 |
President And Fellows Of Harvard College |
Stabilized polypeptide insulin receptor modulators
|
HUE043853T2
(en)
|
2012-10-12 |
2019-09-30 |
Broad Inst Inc |
Gsk3 inhibitors and methods of use thereof
|
EP2909194A1
(en)
|
2012-10-18 |
2015-08-26 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2014063061A1
(en)
|
2012-10-19 |
2014-04-24 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged small molecules as inducers of protein degradation
|
US10000483B2
(en)
|
2012-10-19 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Bone marrow on X chromosome kinase (BMX) inhibitors and uses thereof
|
KR20150082307A
(en)
|
2012-11-01 |
2015-07-15 |
에일러론 테라퓨틱스 인코포레이티드 |
Disubstituted amino acids and methods of preparation and use thereof
|
RS58023B2
(en)
|
2012-11-01 |
2021-12-31 |
Infinity Pharmaceuticals Inc |
Treatment of cancers using pi3 kinase isoform modulators
|
US9567301B2
(en)
|
2012-11-02 |
2017-02-14 |
Dana-Farber Cancer Institute, Inc. |
Pyrrol-1-yl benzoic acid derivatives useful as myc inhibitors
|
CA2869676C
(en)
|
2012-11-21 |
2015-06-23 |
Topokine Therapeutics, Inc. |
Uses and compositions comprising a thiazolidinedione and oleic acid for locally increasing subcutaneous fat
|
LT2922554T
(en)
|
2012-11-26 |
2022-06-27 |
Modernatx, Inc. |
Terminally modified rna
|
JP6408478B2
(en)
|
2012-11-26 |
2018-10-17 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
Trioxacalcin, trioxacalcin-antibody complex and use thereof
|
JP6678455B2
(en)
|
2012-12-21 |
2020-04-08 |
エピザイム,インコーポレイティド |
PRMT5 inhibitors and uses thereof
|
CA2894130A1
(en)
|
2012-12-21 |
2014-06-26 |
Epizyme, Inc. |
Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
|
JP2016505000A
(en)
|
2012-12-21 |
2016-02-18 |
エピザイム,インコーポレイティド |
PRMT5 inhibitors and uses thereof
|
EP2935241A1
(en)
|
2012-12-21 |
2015-10-28 |
Epizyme, Inc. |
Prmt5 inhibitors and uses thereof
|
EP2946014A2
(en)
|
2013-01-17 |
2015-11-25 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
CN105263954B
(en)
|
2013-02-07 |
2019-12-03 |
麻省理工学院 |
The mankind of H5 influenza adapt to
|
JP6494527B2
(en)
|
2013-02-07 |
2019-04-03 |
ザ チルドレンズ メディカル センター コーポレーション |
Protein antigens that provide protection from pneumococcal colonization and / or disease
|
FI3659647T3
(en)
|
2013-02-11 |
2024-03-28 |
Antares Pharma Inc |
Needle assisted jet injection device having reduced trigger force
|
EP2958994B1
(en)
|
2013-02-21 |
2019-05-29 |
Turnstone Limited Partnership |
Vaccine composition
|
ES2742046T3
(en)
|
2013-03-11 |
2020-02-12 |
Antares Pharma Inc |
Dose injector with pinion system
|
WO2014165136A1
(en)
|
2013-03-12 |
2014-10-09 |
Antares Pharma, Inc. |
Constant volume prefilled syringes and kits thereof
|
AU2014244232B2
(en)
|
2013-03-13 |
2019-05-02 |
President And Fellows Of Harvard College |
Stapled and stitched polypeptides and uses thereof
|
US20160024181A1
(en)
|
2013-03-13 |
2016-01-28 |
Moderna Therapeutics, Inc. |
Long-lived polynucleotide molecules
|
US9866924B2
(en)
|
2013-03-14 |
2018-01-09 |
Immersion Corporation |
Systems and methods for enhanced television interaction
|
WO2014151386A1
(en)
|
2013-03-15 |
2014-09-25 |
Infinity Pharmaceuticals, Inc. |
Salts and solid forms of isoquinolinones and composition comprising and methods of using the same
|
US10492990B2
(en)
|
2013-03-15 |
2019-12-03 |
Amgen Inc. |
Drug cassette, autoinjector, and autoinjector system
|
TWI580451B
(en)
|
2013-03-15 |
2017-05-01 |
安美基公司 |
Cassette for an injector and method of using an autoinjector apparatus having an autoinjector and a cassette
|
KR102233251B1
(en)
|
2013-04-03 |
2021-03-26 |
엔-폴드 엘엘씨 |
Novel nanoparticle compositions
|
AU2014248014B2
(en)
|
2013-04-04 |
2018-11-08 |
President And Fellows Of Harvard College |
Macrolides and methods of their preparation and use
|
ES2774330T3
(en)
|
2013-04-09 |
2020-07-20 |
Massachusetts Inst Technology |
Drug supply polymer and uses thereof
|
US10301359B2
(en)
|
2013-04-30 |
2019-05-28 |
Massachusetts Institute Of Technology |
Human adaptation of H3 influenza
|
WO2014179562A1
(en)
|
2013-05-01 |
2014-11-06 |
Massachusetts Institute Of Technology |
1,3,5-triazinane-2,4,6-trione derivatives and uses thereof
|
NO2753788T3
(en)
|
2013-05-10 |
2018-06-16 |
|
|
US20160113932A1
(en)
|
2013-05-30 |
2016-04-28 |
Infinity Pharmaceuticals, Inc. |
Treatment of cancers using pi3 kinase isoform modulators
|
US10526375B2
(en)
|
2013-06-05 |
2020-01-07 |
Massachusetts Institute Of Technology |
Human Adaptation of H7 HA
|
GB2517896B
(en)
|
2013-06-11 |
2015-07-08 |
Cilag Gmbh Int |
Injection device
|
GB2515039B
(en)
|
2013-06-11 |
2015-05-27 |
Cilag Gmbh Int |
Injection Device
|
GB2515032A
(en)
|
2013-06-11 |
2014-12-17 |
Cilag Gmbh Int |
Guide for an injection device
|
GB2515038A
(en)
|
2013-06-11 |
2014-12-17 |
Cilag Gmbh Int |
Injection device
|
US9212145B2
(en)
|
2013-06-11 |
2015-12-15 |
Kala Pharmaceuticals, Inc. |
Urea derivatives and uses thereof
|
BR112015031277A2
(en)
|
2013-06-14 |
2017-09-19 |
Harvard College |
INSULIN RECEPTOR MODULATORS FROM STABILIZED POLYPEPTIDES, INSULIN ANALOGS, PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAID POLYPEPTIDES AND METHODS OF PREPARATION AND USES THEREOF
|
WO2014210397A1
(en)
|
2013-06-26 |
2014-12-31 |
Academia Sinica |
Rm2 antigens and use thereof
|
WO2014210564A1
(en)
|
2013-06-27 |
2014-12-31 |
Academia Sinica |
Glycan conjugates and use thereof
|
BR112016001457A2
(en)
|
2013-07-25 |
2017-08-29 |
Dana Farber Cancer Inst Inc |
TRANSCRIPTION FACTOR INHIBITORS AND THEIR USES
|
SG11201600898YA
(en)
|
2013-08-05 |
2016-03-30 |
Greenlight Biosciences Inc |
Engineered proteins with a protease cleavage site
|
US20160193322A1
(en)
|
2013-08-05 |
2016-07-07 |
Glaxosmithkline Biologicals S.A. |
Combination immunogenic compositions
|
EP3041484B1
(en)
|
2013-09-06 |
2021-03-03 |
Academia Sinica |
Human inkt cell activation using glycolipids with altered glycosyl groups
|
WO2015051241A1
(en)
|
2013-10-04 |
2015-04-09 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
PE20160685A1
(en)
|
2013-10-04 |
2016-07-23 |
Infinity Pharmaceuticals Inc |
HETEROCYCLIC COMPOUNDS AND USES OF THEM
|
US9265881B2
(en)
*
|
2013-10-14 |
2016-02-23 |
Medtronic Minimed, Inc. |
Therapeutic agent injection device
|
US9982009B2
(en)
|
2013-10-15 |
2018-05-29 |
Massachusetts Institute Of Technology |
Methods for treating polycystic kidney disease and polycystic liver disease
|
WO2015057958A2
(en)
|
2013-10-16 |
2015-04-23 |
Massachusetts Institute Of Technology |
Enterobactin conjugates and uses thereof
|
WO2015058140A1
(en)
|
2013-10-18 |
2015-04-23 |
Dana-Farber Cancer Institute, Inc. |
Polycyclic inhibitors of cyclin-dependent kinase 7 (cdk7)
|
WO2015058126A1
(en)
|
2013-10-18 |
2015-04-23 |
Syros Pharmaceuticals, Inc. |
Heteroaromatic compounds useful for the treatment of prolferative diseases
|
WO2015061204A1
(en)
|
2013-10-21 |
2015-04-30 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
MX355330B
(en)
|
2013-11-01 |
2018-04-16 |
Kala Pharmaceuticals Inc |
CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS and USES THEREOF.
|
EP3079739B1
(en)
|
2013-12-11 |
2023-02-22 |
ICU Medical, Inc. |
Check valve
|
ES2709480T3
(en)
|
2013-12-24 |
2019-04-16 |
Harvard College |
Cortistatin analogues and synthesis and uses thereof
|
TW201620939A
(en)
|
2014-01-16 |
2016-06-16 |
中央研究院 |
Compositions and methods for treatment and detection of cancers
|
US10150818B2
(en)
|
2014-01-16 |
2018-12-11 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
EP3099693A4
(en)
|
2014-01-31 |
2017-08-16 |
Dana-Farber Cancer Institute, Inc. |
Uses of diazepane derivatives
|
AU2015217172B2
(en)
|
2014-02-12 |
2019-09-19 |
Amicus Therapeutics, Inc. |
Sugar derivatives comprising sulfur-containing moieties and methods of making same and methods of using the same for the treatment of MPS IIIC
|
CA2941357A1
(en)
|
2014-03-07 |
2015-09-11 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Non-narcotic crmp2 peptides targeting sodium channels for chronic pain
|
JP6701088B2
(en)
|
2014-03-19 |
2020-05-27 |
インフィニティー ファーマシューティカルズ, インコーポレイテッド |
Heterocyclic compounds for use in the treatment of PI3K-gamma mediated disorders
|
CN106415244B
(en)
|
2014-03-27 |
2020-04-24 |
中央研究院 |
Reactive marker compounds and uses thereof
|
DK3122375T3
(en)
|
2014-03-28 |
2021-05-25 |
Univ Washington Through Its Center For Commercialization |
Vaccines against breast and ovarian cancer
|
US9675627B2
(en)
|
2014-04-14 |
2017-06-13 |
Amicus Therapeutics, Inc. |
Dosing regimens for treating and/or preventing cerebral amyloidoses
|
US9862688B2
(en)
|
2014-04-23 |
2018-01-09 |
Dana-Farber Cancer Institute, Inc. |
Hydrophobically tagged janus kinase inhibitors and uses thereof
|
WO2015164614A1
(en)
|
2014-04-23 |
2015-10-29 |
Dana-Farber Cancer Institute, Inc. |
Janus kinase inhibitors and uses thereof
|
WO2015168079A1
(en)
|
2014-04-29 |
2015-11-05 |
Infinity Pharmaceuticals, Inc. |
Pyrimidine or pyridine derivatives useful as pi3k inhibitors
|
US10195113B2
(en)
|
2014-04-30 |
2019-02-05 |
Massachusetts Institute Of Technology |
Adaptor for removal of fluid from vial using a needle-free syringe
|
WO2015168380A1
(en)
|
2014-04-30 |
2015-11-05 |
Massachusetts Institute Of Technology |
Siderophore-based immunization against gram-negative bacteria
|
US10533039B2
(en)
|
2014-05-21 |
2020-01-14 |
President And Fellows Of Harvard College |
Ras inhibitory peptides and uses thereof
|
KR102512592B1
(en)
|
2014-05-27 |
2023-03-21 |
아카데미아 시니카 |
Anti-her2 glycoantibodies and uses thereof
|
KR102576850B1
(en)
|
2014-05-27 |
2023-09-11 |
아카데미아 시니카 |
Fucosidase from bacteroides and methods using the same
|
EP3149036A4
(en)
|
2014-05-27 |
2017-12-27 |
Academia Sinica |
Anti-cd20 glycoantibodies and uses thereof
|
US10118969B2
(en)
|
2014-05-27 |
2018-11-06 |
Academia Sinica |
Compositions and methods relating to universal glycoforms for enhanced antibody efficacy
|
AU2015267044A1
(en)
|
2014-05-28 |
2016-12-15 |
Academia Sinica |
Anti-TNF-alpha glycoantibodies and uses thereof
|
MX2016016533A
(en)
|
2014-06-13 |
2017-05-01 |
Glaxosmithkline Biologicals Sa |
Immunogenic combinations.
|
CN110526912B
(en)
|
2014-06-19 |
2023-02-14 |
武田药品工业株式会社 |
Heteroaryl compounds for kinase inhibition
|
US10188661B2
(en)
|
2014-06-27 |
2019-01-29 |
Topokine Therapeutics, Inc. |
Topical dosage regimen
|
US9840479B2
(en)
|
2014-07-02 |
2017-12-12 |
Massachusetts Institute Of Technology |
Polyamine-fatty acid derived lipidoids and uses thereof
|
EP3169699A4
(en)
|
2014-07-18 |
2018-06-20 |
The University of Washington |
Cancer vaccine compositions and methods of use thereof
|
ES2886553T3
(en)
|
2014-08-10 |
2021-12-20 |
Antares Pharma Inc |
A syringe damper for use in an injection device
|
WO2016025643A1
(en)
|
2014-08-12 |
2016-02-18 |
Massachusetts Institute Of Technology |
Brush-poly(glycoamidoamine)-lipids and uses thereof
|
CN204033941U
(en)
*
|
2014-08-27 |
2014-12-24 |
北京快舒尔医疗技术有限公司 |
A kind of needleless injector with electric functions
|
CN107001404B
(en)
|
2014-09-08 |
2021-06-29 |
中央研究院 |
Activation of human iNKT cells using glycolipids
|
WO2016049355A1
(en)
|
2014-09-24 |
2016-03-31 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles and formulations thereof
|
CN106999541A
(en)
|
2014-09-24 |
2017-08-01 |
艾瑞朗医疗公司 |
Peptidomimetic macrocyclic compound and application thereof
|
US9708348B2
(en)
|
2014-10-03 |
2017-07-18 |
Infinity Pharmaceuticals, Inc. |
Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof
|
TN2017000157A1
(en)
|
2014-10-21 |
2018-10-19 |
Ariad Pharma Inc |
Crystalline forms of 5-chloro-n4-[-2-(dimethylphosphoryl) phenyl]-n2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl) piperidin-1-yl] pyrimidine-2,4-diamine
|
US20180015101A1
(en)
|
2014-10-28 |
2018-01-18 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Compositions and methods for antigen-specific tolerance
|
WO2016077125A1
(en)
|
2014-11-10 |
2016-05-19 |
Moderna Therapeutics, Inc. |
Alternative nucleic acid molecules containing reduced uracil content and uses thereof
|
WO2016086026A1
(en)
|
2014-11-26 |
2016-06-02 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of a therapeutic compound and uses thereof
|
USD786427S1
(en)
|
2014-12-03 |
2017-05-09 |
Icu Medical, Inc. |
Fluid manifold
|
USD793551S1
(en)
|
2014-12-03 |
2017-08-01 |
Icu Medical, Inc. |
Fluid manifold
|
EP3230272B1
(en)
|
2014-12-10 |
2020-08-19 |
Kala Pharmaceuticals, Inc. |
1-amino-triazolo(1,5-a)pyridine-substituted urea derivative and uses thereof
|
CN107206256A
(en)
|
2014-12-23 |
2017-09-26 |
索隆-基特林癌症研究协会 |
The polymorph of Granaticin B
|
EP3236959A4
(en)
|
2014-12-23 |
2018-04-25 |
Dana Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinase 7 (cdk7)
|
US9975965B2
(en)
|
2015-01-16 |
2018-05-22 |
Academia Sinica |
Compositions and methods for treatment and detection of cancers
|
US10495645B2
(en)
|
2015-01-16 |
2019-12-03 |
Academia Sinica |
Cancer markers and methods of use thereof
|
AU2015378564A1
(en)
|
2015-01-24 |
2017-07-13 |
Academia Sinica |
Novel glycan conjugates and methods of use thereof
|
SG11201707750YA
(en)
|
2015-03-20 |
2017-10-30 |
Aileron Therapeutics Inc |
Peptidomimetic macrocycles and uses thereof
|
AU2016243529B2
(en)
|
2015-03-27 |
2021-03-25 |
Dana-Farber Cancer Institute, Inc. |
Inhibitors of cyclin-dependent kinases
|
KR20230048162A
(en)
|
2015-03-30 |
2023-04-10 |
그린라이트 바이오사이언시스, 아이엔씨. |
Cell-free production of ribonucleic acid
|
JP6471029B2
(en)
*
|
2015-04-10 |
2019-02-13 |
株式会社ダイセル |
Syringe
|
EP3288557A4
(en)
|
2015-04-27 |
2018-11-07 |
University of Florida Research Foundation, Inc. |
Metabolically programmed metal chelators and uses thereof
|
WO2016178591A2
(en)
|
2015-05-05 |
2016-11-10 |
Gene Predit, Sa |
Genetic markers and treatment of male obesity
|
EP3307728A4
(en)
|
2015-06-12 |
2019-07-17 |
Dana Farber Cancer Institute, Inc. |
Combination therapy of transcription inhibitors and kinase inhibitors
|
CN113968823A
(en)
|
2015-06-19 |
2022-01-25 |
麻省理工学院 |
Alkenyl substituted 2, 5-piperazinediones and their use in compositions for delivering an agent to a subject or cell
|
US10059741B2
(en)
|
2015-07-01 |
2018-08-28 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles
|
US10179128B2
(en)
|
2015-08-31 |
2019-01-15 |
Amicus Therapeutics, Inc. |
Regimens for treating and preventing lysosomal disorders and degenerative disorders of the central nervous system
|
JP7028766B2
(en)
|
2015-09-09 |
2022-03-02 |
ダナ-ファーバー キャンサー インスティテュート, インコーポレイテッド |
Inhibitor of cyclin-dependent kinase
|
WO2017044633A1
(en)
|
2015-09-10 |
2017-03-16 |
Aileron Therapeutics, Inc. |
Peptidomimetic macrocycles as modulators of mcl-1
|
DK3350333T3
(en)
|
2015-09-17 |
2022-01-31 |
Modernatx Inc |
POLYNUCLEOTIDES CONTAINING A STABILIZING TAIL REGION
|
HUE057613T2
(en)
|
2015-09-17 |
2022-05-28 |
Modernatx Inc |
Compounds and compositions for intracellular delivery of therapeutic agents
|
WO2017059389A1
(en)
|
2015-10-01 |
2017-04-06 |
Kythera Biopharmaceuticals, Inc. |
Compositions comprising a statin for use in methods of adipolysis
|
GB201518684D0
(en)
|
2015-10-21 |
2015-12-02 |
Glaxosmithkline Biolog Sa |
Vaccine
|
AU2016349632A1
(en)
|
2015-11-07 |
2018-05-24 |
Multivir Inc. |
Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
DK3394030T3
(en)
|
2015-12-22 |
2022-03-28 |
Modernatx Inc |
COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR RELEASE OF FUNDS
|
MX2018010586A
(en)
|
2016-03-02 |
2019-03-28 |
Univ Texas |
Sting activating nanovaccine for immunotherapy.
|
JP2019515876A
(en)
|
2016-03-08 |
2019-06-13 |
アカデミア シニカAcademia Sinica |
Methods for module synthesis of N-glycans and their arrays
|
US10759806B2
(en)
|
2016-03-17 |
2020-09-01 |
Infinity Pharmaceuticals, Inc. |
Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors
|
RU2018138975A
(en)
|
2016-04-06 |
2020-05-12 |
Гринлайт Байосайенсис, Инк. |
CELL-FREE PRODUCTS OF RNA
|
SG11201810758WA
(en)
|
2016-06-03 |
2018-12-28 |
Sanofi Pasteur Inc |
Modification of engineered influenza hemagglutinin polypeptides
|
WO2017214337A1
(en)
|
2016-06-07 |
2017-12-14 |
Massachusetts Institute Of Technology |
Drug delivery polymers and uses thereof
|
WO2017214269A1
(en)
|
2016-06-08 |
2017-12-14 |
Infinity Pharmaceuticals, Inc. |
Heterocyclic compounds and uses thereof
|
WO2017218704A1
(en)
|
2016-06-14 |
2017-12-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
GB201610599D0
(en)
|
2016-06-17 |
2016-08-03 |
Glaxosmithkline Biologicals Sa |
Immunogenic Composition
|
NL2017294B1
(en)
|
2016-08-05 |
2018-02-14 |
Univ Erasmus Med Ct Rotterdam |
Natural cryptic exon removal by pairs of antisense oligonucleotides.
|
EA039427B1
(en)
|
2016-08-05 |
2022-01-26 |
Санофи Пастер Инк. |
Multivalent pneumococcal polysaccharide-protein conjugate composition
|
MX2019001342A
(en)
|
2016-08-05 |
2019-07-04 |
Sanofi Pasteur Inc |
Multivalent pneumococcal polysaccharide-protein conjugate composition.
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
JP7213549B2
(en)
|
2016-08-22 |
2023-01-27 |
シーエイチオー ファーマ インコーポレイテッド |
Antibodies, Binding Fragments, and Methods of Use
|
US10030933B2
(en)
*
|
2016-08-25 |
2018-07-24 |
Thomas Gore Living Trust |
Gas spring assembly and a catch therefor
|
KR101838631B1
(en)
*
|
2016-11-03 |
2018-04-26 |
서울대학교 산학협력단 |
Automatic recharging micro-jet drug injection device preventing jet speed down problem of repeated injection
|
US11583504B2
(en)
|
2016-11-08 |
2023-02-21 |
Modernatx, Inc. |
Stabilized formulations of lipid nanoparticles
|
KR101863355B1
(en)
*
|
2016-12-01 |
2018-06-01 |
한국기계연구원 |
A Pressure-Increasing Needle Free Syringe for Variable Injection
|
WO2018106738A1
(en)
|
2016-12-05 |
2018-06-14 |
Massachusetts Institute Of Technology |
Brush-arm star polymers, conjugates and particles, and uses thereof
|
CN110381997A
(en)
|
2016-12-12 |
2019-10-25 |
茂体外尔公司 |
For treating and preventing the method and composition comprising gene-virus therapy and immunologic test point inhibitor of cancer and infectious diseases
|
KR20190108104A
(en)
|
2016-12-31 |
2019-09-23 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
Use of Sublingual Dexmedetomidine for Treatment of Anxiety
|
PL3596041T3
(en)
|
2017-03-15 |
2023-03-06 |
Modernatx, Inc. |
Compound and compositions for intracellular delivery of therapeutic agents
|
EP3595727A1
(en)
|
2017-03-15 |
2020-01-22 |
ModernaTX, Inc. |
Lipid nanoparticle formulation
|
WO2018175324A1
(en)
|
2017-03-20 |
2018-09-27 |
The Broad Institute, Inc. |
Compounds and methods for regulating insulin secretion
|
US11203601B2
(en)
|
2017-04-05 |
2021-12-21 |
The Broad Institute, Inc. |
Tricyclic compounds as glycogen synthase kinase 3 (GSK3) inhibitors and uses thereof
|
WO2018195552A1
(en)
|
2017-04-21 |
2018-10-25 |
Sillajen, Inc. |
Oncolytic vaccinia virus and checkpoint inhibitor combination therapy
|
KR20190134807A
(en)
|
2017-04-25 |
2019-12-04 |
아미쿠스 세라퓨틱스, 인코포레이티드 |
Novel compositions for preventing and / or treating degenerative diseases and / or lysosomal reservoirs of the central nervous system
|
EP3638678A1
(en)
|
2017-06-14 |
2020-04-22 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of agents
|
JP2020525540A
(en)
|
2017-06-23 |
2020-08-27 |
ノソコミアル ヴァクスィーン コーポレイション |
Immunogenic composition
|
WO2019013789A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds
|
WO2019013790A1
(en)
|
2017-07-12 |
2019-01-17 |
Curza Global, Llc |
Antimicrobial compounds and uses thereof
|
US11440000B2
(en)
|
2017-07-27 |
2022-09-13 |
Biomerieux, Inc. |
Isolation tube with an endcap
|
JP7275111B2
(en)
|
2017-08-31 |
2023-05-17 |
モデルナティエックス インコーポレイテッド |
Method for producing lipid nanoparticles
|
CN111465701A
(en)
|
2017-10-11 |
2020-07-28 |
绿光生物科技股份有限公司 |
Methods and compositions for nucleoside triphosphate and ribonucleic acid generation
|
US11786477B2
(en)
|
2017-12-01 |
2023-10-17 |
North Carolina State University |
Fibrin particles and methods of making the same
|
WO2019124852A1
(en)
|
2017-12-19 |
2019-06-27 |
조민수 |
Needleless injection syringe
|
GB201721582D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
S aureus antigens and immunogenic compositions
|
GB201721576D0
(en)
|
2017-12-21 |
2018-02-07 |
Glaxosmithkline Biologicals Sa |
Hla antigens and glycoconjugates thereof
|
US20200385758A1
(en)
|
2018-01-05 |
2020-12-10 |
Ottawa Hospital Research Institute |
Modified vaccinia vectors
|
JP2021518408A
(en)
|
2018-03-19 |
2021-08-02 |
マルチビア インコーポレイテッド |
Methods and Compositions Containing Tumor Suppressor Gene Therapies and CD122 / CD132 Agonists for Cancer Treatment
|
KR20210028192A
(en)
|
2018-06-27 |
2021-03-11 |
바이오엑셀 테라퓨틱스 인코포레이티드 |
Film formulation containing dexmedetomidine and method for producing same
|
CA3113436A1
(en)
|
2018-09-19 |
2020-03-26 |
Modernatx, Inc. |
Compounds and compositions for intracellular delivery of therapeutic agents
|
EP3852728A1
(en)
|
2018-09-20 |
2021-07-28 |
Modernatx, Inc. |
Preparation of lipid nanoparticles and methods of administration thereof
|
US11160791B2
(en)
|
2018-11-01 |
2021-11-02 |
Medefil, Inc. |
Dexmedetomidine injection premix formulation in ready to use (RTU) bags
|
JP7429650B2
(en)
*
|
2018-12-27 |
2024-02-08 |
株式会社ダイセル |
needleless syringe
|
AU2020209170A1
(en)
|
2019-01-16 |
2021-08-12 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
EP3911643A1
(en)
|
2019-01-16 |
2021-11-24 |
Curza Global LLC |
Antimicrobial compounds and methods
|
CN111481774B
(en)
*
|
2019-01-25 |
2023-06-09 |
凯联医疗科技(上海)有限公司 |
Needleless syringe for trace medicine
|
CN113939282A
(en)
|
2019-01-31 |
2022-01-14 |
摩登纳特斯有限公司 |
Method for preparing lipid nanoparticles
|
WO2020168466A1
(en)
|
2019-02-19 |
2020-08-27 |
Stemirna Therapeutics Co., Ltd. |
Modified nucleoside and synthetic methods thereof
|
BR112022000992A2
(en)
|
2019-07-19 |
2022-06-14 |
Arx Llc |
Non-sedating dexmedetomidine treatment regimens
|
US20220280639A1
(en)
|
2019-07-31 |
2022-09-08 |
Modernatx, Inc. |
Compositions and methods for delivery of rna interference agents to immune cells
|
AU2020323498A1
(en)
|
2019-07-31 |
2022-03-03 |
Sk Bioscience Co., Ltd. |
Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
|
KR102269721B1
(en)
*
|
2019-08-13 |
2021-06-28 |
주식회사 쿼드메디슨 |
Micro-needle bullet injection apparaus for endoscope
|
US20230278987A1
(en)
|
2019-11-13 |
2023-09-07 |
Curza Global, Llc |
Antimicrobial Compounds and Methods
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
US11752269B2
(en)
*
|
2019-12-18 |
2023-09-12 |
Integrimedical Llc |
Spring loaded medical needle-free injection system
|
TW202139976A
(en)
|
2020-01-31 |
2021-11-01 |
美商現代公司 |
Methods of preparing lipid nanoparticles
|
WO2021173965A1
(en)
|
2020-02-28 |
2021-09-02 |
Massachusetts Institute Of Technology |
Identification of variable influenza residues and uses thereof
|
JP7386857B2
(en)
*
|
2020-04-30 |
2023-11-27 |
ベイジン キューエス メディカル テクノロジー カンパニー,リミテッド |
Needleless syringe injection head, needleless syringe body and needleless syringe
|
WO2021231729A1
(en)
|
2020-05-13 |
2021-11-18 |
Sanofi |
Adjuvanted stabilized stem hemagglutinin nanoparticles and methods of using the same to induce broadly neutralizing antibodies against influenza
|
JPWO2022092295A1
(en)
|
2020-10-30 |
2022-05-05 |
|
|
CN117083065A
(en)
|
2020-10-30 |
2023-11-17 |
庆应义塾 |
Novel treatment and prevention of sarcopenia-related diseases and the like
|
TW202237068A
(en)
|
2020-12-09 |
2022-10-01 |
美商建南德克公司 |
High-throughput methods for preparing lipid nanoparticles and uses thereof
|
WO2022192176A1
(en)
|
2021-03-09 |
2022-09-15 |
Massachusetts Institute Of Technology |
Branched poly(-amino esters) for the delivery of nucleic acids
|
TW202313065A
(en)
|
2021-05-28 |
2023-04-01 |
美商季卡尼醫療公司 |
Compounds for treating genetic diseases
|
CN113318301A
(en)
*
|
2021-06-28 |
2021-08-31 |
北京科技大学 |
Large-dose porous needleless injector
|
WO2023018817A1
(en)
|
2021-08-11 |
2023-02-16 |
Sanofi Pasteur Inc. |
Truncated influenza neuraminidase and methods of using the same
|
US20230233667A1
(en)
|
2021-09-08 |
2023-07-27 |
Affinivax, Inc. |
Coronavirus vaccine
|
TW202333778A
(en)
|
2021-10-08 |
2023-09-01 |
美商賽諾菲巴斯德公司 |
Multivalent influenza vaccines
|
WO2023081798A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi Pasteur Inc. |
Multivalent influenza vaccines comprising recombinant hemagglutinin and neuraminidase and methods of using the same
|
WO2023079113A1
(en)
|
2021-11-05 |
2023-05-11 |
Sanofi |
Hybrid multivalent influenza vaccines comprising hemagglutinin and neuraminidase and methods of using the same
|
WO2023114889A1
(en)
|
2021-12-16 |
2023-06-22 |
Modernatx, Inc. |
Processes for preparing lipid nanoparticles
|
GB2614309A
(en)
|
2021-12-24 |
2023-07-05 |
Stratosvir Ltd |
Improved vaccinia virus vectors
|
WO2023129963A1
(en)
|
2021-12-30 |
2023-07-06 |
Curza Global, Llc |
Antimicrobial compounds and methods
|
WO2023144206A1
(en)
|
2022-01-27 |
2023-08-03 |
Sanofi Pasteur |
Modified vero cells and methods of using the same for virus production
|
WO2023144393A1
(en)
|
2022-01-28 |
2023-08-03 |
Fundació Centre De Regulació Genòmica |
Therapeutic cytokines and methods
|
US11524105B1
(en)
*
|
2022-03-03 |
2022-12-13 |
Hetaida Technology Co., Ltd. |
Nasal aspirator capable of effectively preventing backflow and control method thereof
|
WO2023177577A1
(en)
|
2022-03-14 |
2023-09-21 |
Sanofi Pasteur Inc. |
Machine-learning techniques in protein design for vaccine generation
|
WO2023193002A1
(en)
|
2022-04-01 |
2023-10-05 |
Modernatx, Inc. |
Cross mixers for lipid nanoparticle production, and methods of operating the same
|
WO2023235380A1
(en)
|
2022-06-01 |
2023-12-07 |
Zikani Therapeutics, Inc. |
Macrolides for treating genetic diseases
|
CN114870163B
(en)
*
|
2022-06-06 |
2023-12-19 |
江苏乐聚医药科技有限公司 |
Air spring mixed needleless injector
|
WO2023250513A1
(en)
|
2022-06-24 |
2023-12-28 |
Zikani Therapeutics, Inc. |
13-membered macrolide compounds for treating diseases mediated by abnormal protein translation
|
WO2024026487A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising phospholipid derivatives and related uses
|
WO2024026482A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Lipid nanoparticle compositions comprising surface lipid derivatives and related uses
|
WO2024026475A1
(en)
|
2022-07-29 |
2024-02-01 |
Modernatx, Inc. |
Compositions for delivery to hematopoietic stem and progenitor cells (hspcs) and related uses
|
WO2024049994A1
(en)
|
2022-09-01 |
2024-03-07 |
Zikani Therapeutics, Inc. |
Treatment of familial adenomatous polyopsis using a 13-membered macrolide
|
CN115429974B
(en)
*
|
2022-09-07 |
2023-09-15 |
北京快舒尔医疗技术有限公司 |
Needleless injector
|